Jagged1 (JAG1): Structure, expression, and disease associations

Gene

Volumn 576, Issue 1, 2016, Pages 381-384

  Grochowski, Christopher M ^a   Loomes, Kathleen M ^a,b   Spinner, Nancy B ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alagille syndrome; Developmental disorder; Jagged1; Notch signaling; Tetralogy of Fallot

Indexed keywords

JAGGED1; CALCIUM BINDING PROTEIN; JAG1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN JAGGED 1; SERRATE JAGGED PROTEIN; SIGNAL PEPTIDE;

ADRENAL CORTEX CARCINOMA; ALAGILLE SYNDROME; BREAST CANCER; EXPERIMENTAL MOUSE; FALLOT TETRALOGY; GENE INACTIVATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOINSUFFICIENCY; HUMAN; HUMAN DEVELOPMENT; LOSS OF FUNCTION MUTATION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PULMONARY VALVE STENOSIS; REVIEW; GENE SILENCING; GENETIC PREDISPOSITION; GENETICS; NEOPLASM;

ALAGILLE SYNDROME; CALCIUM-BINDING PROTEINS; GENE KNOCKDOWN TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JAGGED-1 PROTEIN; MEMBRANE PROTEINS; NEOPLASMS; PULMONARY VALVE STENOSIS; SERRATE-JAGGED PROTEINS; TETRALOGY OF FALLOT;

EID: 84949595764     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.10.065     Document Type: Review

References (45)

1. Adam J., Myat A., Le Roux I., Eddison M., Henrique D., Ish-Horowicz D., Lewis J. Cell fate choices and the expression of Notch, Delta and Serrate homologues in the chick inner ear: parallels with Drosophila sense-organ development. Development 1998, 125:4645-4654.
2. Artavanis-Tsakonas S., Muskavitch M., Yedvobnick B. Molecular cloning of Notch, a locus affecting neurogenesis in Drosophila melanogaster. Proc. Natl. Acad. Sci. 1983, 80:1977-1981.
3. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 30:770-776.
4. Bauer R.C., Laney A.O., Smith R., Gerfen J., Morrissette J.J., Woyciechowski S., Garbarini J., Loomes K.M., Krantz I.D., Urban Z., Gelb B.D., Goldmuntz E., Spinner N.B. Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum. Mutat. 2010, 31:594-601.
5. Cheng H.-T., Kopan R. The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney. Kidney Int. 2005, 68:1951-1952.
6. Chillakuri C.R., Sheppard D., Lea S.M., Handford P.A. Notch receptor-ligand binding and activation: insights from molecular studies. Semin. Cell Dev. Biol. 2012, 23:421-428.
7. Crosnier C., Attie-Bitach T., Encha-Razavi F., Audollent S., Soudy F., Hadchouel M., Meunier-Rotival M., Vekemans M. JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 2000, 32:574-581.
8. Dickson B.C., Mulligan A.M., Zhang H., Lockwood G., Malley F.P., Egan S.E., Reedijk M. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod. Pathol. 2007, 20:685-693. O&apos.
9. Eldadah Z.A., Hamosh A., Biery N.J., Montgomery R.A., Duke M., Elkins R., Dietz H.C. Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Hum. Mol. Genet. 2001, 10:163-169.
10. Ellisen L.W., Bird J., West D.C., Soreng A.L., Reynolds T.C., Smith S.D., Sklar J. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991, 66:649-661.
11. Gasperowicz M., Otto F. The notch signalling pathway in the development of the mouse placenta. Placenta 2008, 29:651-659.
12. Guarnaccia C., Pintar A., Pongor S. Exon 6 of human Jagged-1 encodes an autonomously folding unit. FEBS Lett. 2004, 574:156-160.
13. High F.A., Epstein J.A. The multifaceted role of Notch in cardiac development and disease. Nat. Rev. Genet. 2008, 9:49-61.
14. High F.A., Lu M.M., Pear W.S., Loomes K.M., Kaestner K.H., Epstein J.A. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. 2008, 105:1955-1959.
15. Hofmann J.J., Zovein A.C., Koh H., Radtke F., Weinmaster G., Iruela-Arispe M.L. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development 2010, 137:4061-4072.
16. Hofmann J.J., Briot A., Enciso J., Zovein A.C., Ren S., Zhang Z.W., Radtke F., Simons M., Wang Y., Iruela-Arispe M.L. Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome. Development 2012, 139:4449-4460.
17. Humphreys R., Zheng W., Prince L.S., Qu X., Brown C., Loomes K., Huppert S.S., Baldwin S., Goudy S. Cranial neural crest ablation of Jagged1 recapitulates the craniofacial phenotype of Alagille syndrome patients. Hum. Mol. Genet. 2012, 6:1374-1383.
18. Jones E.A., Clement-Jones M., Wilson D.I. JAGGED1 expression in human embryos: correlation with the Alagille syndrome phenotype. J. Med. Genet. 2000, 37:658-662.
19. Kamath B.M., Bason L., Piccoli D.A., Krantz I.D., Spinner N.B. Consequences of JAG1 mutations. J. Med. Genet. 2003, 40:891-895.
20. Kamath B.M., Bauer R.C., Loomes K.M., Chao G., Gerfen J., Hutchinson A., Hardikar W., Hirschfield G., Jara P., Krantz I.D., Lapunzina P., Leonard L., Ling S., Ng V.L., Hoang P.L., Piccoli D.A., Spinner N.B. NOTCH2 mutations in Alagille syndrome. J. Med. Genet. 2012, 49:138-144.
21. Kamath B.M., Spinner N.B., Rosenblum N.D. Renal involvement and the role of Notch signalling in Alagille syndrome. Nat. Rev. Nephrol. 2013, 9:409-418.
22. Kiernan A.E., Ahituv N., Fuchs H., Balling R., Avraham K.B., Steel K.P., Hrabé de Angelis M. The Notch ligand Jagged1 is required for inner ear sensory development. PNAS 2001, 98:3873-3878.
23. Kopan R., Ilagan M.X.G. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009, 137:216-233.
24. Krantz I.D., Piccoli D.A., Spinner N.B. Alagille syndrome. J. Med. Genet. 1997, 34:152-157.
25. Krantz I.D., Colliton R.P., Genin A., Rand E.B., Li L., Piccoli D.A., Spinner N.B. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am. J. Hum. Genet. 1998, 62:1361-1369.
26. Li L., Krantz I.D., Deng Y., Genin A., Banta A.B., Collins C.C., Qi M., Trask B.J., Kuo W.L., Cochran J., Costa T., Pierpont M.E., Rand E.B., Piccoli D.A., Hood L., Spinner N.B. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nature 1997, 16:243-251.
27. Li D., Masiero M., Banham A.H., Harris A.L. The notch ligand JAGGED1 as a target for anti-tumor therapy. Front. Oncol. 2014, 4:1-13.
28. Lindsell C.E., Shawber C.J., Boulter J., Weinmaster G. Jagged: a mammalian ligand that activates notch1. Cell 1995, 80:909-917.
29. Loomes K.M., Underkoffler L.A., Morabito J., Gottlieb S., Piccoli D.A., Spinner N.B., Baldwin H.S., Oakey R.J. The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome. Hum. Mol. Genet. 1999, 8:2443-2449.
30. Loomes K.M., Russo P., Ryan M., Nelson A., Underkoffler L., Glover C., Fu H., Gridley T., Kaestner K.H., Oakey R.J. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: effects of gene dosage. Hepatology 2007, 45:323-330.
31. Lu C., Bonome T., Li Y., Kamat A.A., Han L.Y., Schmandt R., Coleman R.L., Gershenson D.M., Jaffe R.B., Birrer M.J. Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer Res. 2007, 67:1757-1768.
32. McCright B., Gao X., Shen L., Lozier J., Lan Y., Maguire M., Herzlinger D., Weinmaster G., Jiang R., Gridley T. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001, 128:491-502.
33. McCright B., Lozier J., Gridley T. A mouse model of alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002, 129:1075-1082.
34. McDaniell R., Warthen D.M., Sanchez-Lara P.A., Pai A., Krantz I.D., Piccoli D.A., Spinner N.B. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 2006, 79:169-173.
35. Mohr O.L. Character changes caused by mutation of an entire region of a chromosome in Drosophila. Genetics 1919, 4:275.
36. Morrissette J.D., Colliton R.P., Spinner N.B. Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome. Hum. Mol. Genet. 2001, 10:405-413.
37. Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A., Piccoli D.A., Meltzer P.S., Spinner N.B., Collins F.S., Chandrasekharappa S.C. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet. 1997, 16:235-242.
38. Penton A.L., Leonard L.D., Spinner N.B. Notch signaling in human development and disease. Semin. Cell Dev. Biol. 2012, 23:450-457.
39. Reedijk M., Odorcic S., Chang L., Zhang H., Miller N., McCready D.R., Lockwood G., Egan S.E. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005, 65:8530-8537.
40. Shimizu K., Chiba S., Saito T., Kumano K., Hirai H. Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. Biochem. Biophys. Res. Commun. 2000, 276:385-389.
41. Simon D.P., Giordano T.J., Hammer G.D. Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma. Clin. Cancer Res. 2012, 18:2452-2464.
42. Thakurdas S.M., Lopez M.F., Kakuda S., Fernandez-Valdivia R., Zarrin-Khameh N., Haltiwanger R.S., Jafar-Nejad H. Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi). Hepatology 2015.
43. Turnpenny P.D., Ellard S. Alagille syndrome: pathogenesis, diagnosis and management. Eur. J. Hum. Genet. 2012, 20:251-257.
44. Warthen D.M., Moore E.C., Kamath B.M., Morrissette J.J., Sanchez-Lara P.A., Piccoli D.A., Krantz I.D., Spinner N.B. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum. Mutat. 2006, 27:436-443.
45. Xue Y., Gao X., Lindsell C.E., Norton C.R., Chang B., Hicks C., Gendron-Maguire M., Rand E.B., Weinmaster G., Gridley T. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8:723-730.